2016 American Transplant Congress

June 11-15, 2016 in Boston, MA

View by Title View Sessions

View by Date

Jump to: [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z

Hand-Assisted Laparoscopic Donor Nephrectomy: Experience with Over 2400 Cases at a Single Center.

H. Li,^1,2 M. Stegall,¹ G. Chow,¹ P. Dean,¹ J. Heimbach,¹ T. Taner,¹ M. Prieto.¹
Have We Gone Too Far Defining Performance Outliers? One-Third of Kidney Transplant Programs Now Identified for Low Performance within Three Years.

J. Schold,¹ C. Miller,¹ M. Henry,² L. Buccini,¹ S. Flechner,¹ D. Goldfarb,¹ E. Poggio,¹ K. Andreonni.³
HCK Is a Potential Mediator of Renal Fibrosis.

C. Wei,¹ M. Menon,¹ L. Li,² Z. Yi,¹ K. Keung,³ C. Woytovich,¹ I. Greene,¹ W. Zhang,¹ J. He,¹ B. Murphy.¹
HCV, Acute Rejection, and the New Direct-Acting Antivirals in Deceased Donor Kidney Transplant Recipients.

C. Liao, A. Massie, S. Bae, D. Segev.
Health Disparities in Pediatric Intestinal Transplantation: Before and After the Implementation of MELD/PELD.

V. Cohran,¹ S. Mohammed,¹ J. Prozialeck,¹ A. Gaddam,¹ J. Caicedo.²
Health Insurance Trends in United States Living Kidney Donors.

J. Rodrigue,^1,2 A. Fleishman.¹
Heart and Kidney Transplants in Patients with Mechanical Circulatory Support: Who Needs a Kidney?

J. Neyer, J. Patel, M. Kittleson, D. Chang, M. Luu, T. Aintablian, E. Passano, L. Czer, F. Esmailian, J. Kobashigawa.
Heat Shock Protein 90 Inhibitor 17DMAG Is a Potential New Therapeutic Agent Against Acute Allograft Rejection.

T. Maehana,¹ T. Tanaka,¹ H. Kitamura,² N. Masumori.¹
Hematopoietic Cell Transplant and Solid Organ Transplantation: A First Report of the U.S. Experience.

M. Gupta, M. Levine, P. Abt.
Hematopoietic Progenitor Cells and Monocyte Subsets and Hepatic Decompensation in Patients Referred for Liver Transplant Evaluation.

K. Forde,¹ K. Krok,² M. Patel,¹ M. Krowka,³ M. Fallon,⁴ S. Kawut.¹

Jump to: [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z